Recent news coverage for Westlake Chemical Partners LP includes earnings call highlights, dividend reports, and earnings transcripts from 2025 through 2026, reflecting ongoing investor communications and market activity.

• Westlake Chemical Partners held a Q2 earnings call highlighting operational and financial results in August 2026 [N2].
• Dividend reports in November 2026 and August 2026 included Westlake Chemical Partners among companies distributing dividends [N1][N3].
• The Q1 2026 earnings transcript was published in May 2026, providing detailed financial and operational insights [N4].
• Regular dividend reports in May 2026 featured Westlake Chemical Partners alongside other companies [N5].
• Earnings were reported in February 2026, with accompanying market commentary [N6].
• An ex-dividend reminder including Westlake Chemical Partners was issued in February 2026 [N7].
• An earnings call transcript from October 2025 provided historical context on financial performance [N8].

The partnership benefits from a stable contractual relationship with Westlake Corporation that ensures a minimum volume of ethylene sales with cost-plus pricing, providing revenue visibility. Strong liquidity ratios as of September 30, 2026, indicate financial flexibility. The partnership's ability to recover operating and maintenance costs through the Ethylene Sales Agreement supports margin stability. Regular investor communications and earnings call highlights demonstrate active management engagement and transparency.

The partnership's exposure to variable rate debt introduces interest rate risk, which could increase interest expenses if rates rise. The Buyer Deficiency Fee indicates risk if Westlake Corporation purchases less than committed volumes, potentially impacting revenue. Commodity price fluctuations affect the portion of ethylene sold to third parties, which is subject to market volatility. The partnership's financial performance is also sensitive to operational risks inherent in chemical production facilities. Changes in market demand or disruptions could affect future results.

Westlake Chemical Partners LP's business model is supported by a long-term Ethylene Sales Agreement with Westlake Corporation, which provides revenue stability through minimum purchase commitments and a pricing mechanism that recovers operating and capital costs plus a margin. This contractual arrangement limits exposure to commodity price volatility for the majority of ethylene production. The partnership's integration with Westlake subsidiaries and the scale of its production facilities contribute to operational efficiencies. The effective internal controls and transparent financial reporting further support investor confidence. However, the partnership remains exposed to interest rate risk due to variable rate debt and to market demand fluctuations beyond the committed volumes.

• Interest Rate Risk: The partnership's outstanding debt is variable rate and owed to Westlake subsidiaries, exposing it to interest rate fluctuations that could increase interest expense.
• Buyer Deficiency Fee Risk: If Westlake Corporation purchases less than its annual ethylene commitment, the partnership recognizes a Buyer Deficiency Fee, which could impact revenue.
• Commodity Price Exposure: Approximately 5% of ethylene production is sold to third parties and subject to commodity price volatility, which may affect profitability.
• Operational Risks: The partnership has conditional asset retirement obligations related to hazardous materials and manufacturing facilities, with indeterminate settlement dates and potential financial impact.

• Westlake Chemical Partners LP operates as a partnership with a business model centered on ethylene production and sales, primarily to Westlake Corporation under a long-term Ethylene Sales Agreement.
• The Ethylene Sales Agreement requires Westlake Corporation to purchase a minimum volume of ethylene annually, with pricing based on feedstock costs, operating costs, maintenance capital expenditures, and a fixed margin.
• The partnership recognized net sales to Westlake of approximately $1.033 billion for the year ended December 31, 2025, with additional sales to third parties.
• The partnership's revenue for the nine months ended September 30, 2026, was $314.459 million, with net income of $16.219 million for the same period.
• As of September 30, 2026, the partnership held $47.649 million in cash and cash equivalents and had current assets of $184.47 million against current liabilities of $52.451 million, resulting in a current ratio of 3.52 and a cash ratio of 0.91, indicating strong liquidity.
• The partnership's debt is variable rate debt owed to wholly-owned subsidiaries of Westlake, with a weighted average interest rate of 5.8% as of December 31, 2025.
• The partnership's management assessed internal control over financial reporting as effective as of December 31, 2025, with an unqualified opinion from the independent auditor.
• The partnership recognizes a Buyer Deficiency Fee if Westlake Corporation purchases less than its annual ethylene commitment; $6 million was recognized in 2025.
• The partnership's consolidated financial statements show total assets of approximately $1.257 billion and total equity of $802.352 million as of December 31, 2025.
• Recent news coverage includes earnings call highlights, dividend reports, and earnings transcripts from 2025 through 2026, indicating ongoing investor communications and market interest.